×

Food and Staples Retailing Drug Retail

  • RENO, Nev.— Nevada voters legalized recreational marijuana in November, and officials are trying to put rules in place to start selling it on July 1. But Nevada's quick timeline faces a major hurdle: A legal battle between the state and the powerful liquor lobby over who can distribute the drug to retailers. Oregon and Colorado each raised about $3.5 million in tax...

  • Allergan CEO on the battle over drug pricing

    CNBC's Meg Tirrell talks to Brent Saunders, Allergan CEO, about an executive order on possibly lowering drug prices live from the Heartland Health Summit.

  • SANTIAGO, May 10- Pharmacies in Chile's capital Santiago will start selling cannabis-based medicines this week, the first time such treatments have been offered by drug stores in Latin America, the companies behind the launch said on Wednesday. Chile legalized the use of medical marijuana in 2015 and is among a number of Latin American countries gradually...

  • *Q1 adj EPS $1.17 vs est $1.10. May 2- CVS Health Corp reported a bigger-than-expected quarterly profit as higher margins in its pharmacy business helped offset the loss of major contracts last year. Same-store prescription volumes fell 460 basis points in the first quarter due to the loss of contracts to fill prescriptions for Tricare, a U.S. Department of...

  • Same-store sales at the front-end of stores, where the company sells beauty products, snacks and over-the-counter drugs, also fell 4.9 percent in the first quarter ended March 31. Net income attributable to CVS fell to $952 million, or 92 cents per share, in the first quarter ended March 31, from $1.15 billion, or $1.04 per share, a year earlier. Interest expense fell...

  • May 2- Drugstore chain and pharmacy benefits manager CVS Health Corp reported a 17 percent drop in quarterly profit, as it filled fewer prescriptions at its pharmacies and lower traffic hurt sales at the front-end of its stores. Net income attributable to CVS fell to $952 million, or 92 cents per share, in the first quarter ended March 31, from $1.15 billion, or $1.04...

  • What to expect from biotech

    CNBC's Meg Tirrell discusses what healthcare investors should expect from the biotech sector. With the "Fast Money" traders.

  • President Donald Trump meets with representatives from PhRMA, the Pharmaceutical Research and Manufacturers of America, in the Roosevelt Room of the White House on Jan. 31, 2017, in Washington, DC.

    Discussing who is to blame for higher drug pricing with Mark Merritt, PCMA CEO; Stephen Ubl, Pharmaceutical Research and Manufacturers of America (PhRMA) president and ceo; and CNBC's Meg Tirrell.

  • April 19- Canadian grocery and pharmacy retailer Loblaw Cos Ltd said on Wednesday it would sell its gas station business to asset manager Brookfield Business Partners LP for about C $540 million.

  • The next billion dollar drugs

    CNBC's Meg Tirrell breaks down the top five new drugs to bring in blockbuster sales.

  • April 5- Drugstore chain operator Walgreens Boots Alliance Inc reported a surprise drop in quarterly sales on Wednesday, citing challenging market conditions in Europe and the impact of a stronger dollar. The company also said it would repurchase up to $1 billion worth of shares until Dec. 31. Sales in its wholesale business, which also operates in Europe, fell...

  • April 5- Drugstore chain operator Walgreens Boots Alliance Inc, reported a surprise drop in quarterly sales, citing challenging market conditions in continental Europe, and as a strong dollar reduced the value of sales outside the United States. Walgreens in January reduced its offer price to $6.50- $7.00 per share from $9.00, valuing Rite Aid at $6.84 billion-...

  • April 5- Drugstore chain operator Walgreens Boots Alliance Inc, reported a surprise drop in quarterly sales, citing "challenging market conditions in continental Europe" and as a strong dollar reduced the value of sales outside the United States. Net income attributable to the company, rose to $1.06 billion, or 98 cents per share, in the second quarter ended Feb. 28,...

  • Shedding light on Alzheimer’s

    What goes wrong in the brain in Alzheimer’s disease is one of the great mysteries of medicine. New research out of MIT may shed light on the problem. CNBC's Meg Tirrell reports the latest.

  • Regeneron's new drug

    CNBC's Meg Tirrell reports the latest on Regeneron Pharmaceuticals getting FDA approval for potentially an important drug.

  • NEW YORK, March 20- Trading in Sprouts Farmers Market Inc's shares and options surged last week ahead of a report that the natural-foods retailer was the subject of merger talks, raising questions about whether news of a possible deal was leaked. On Sunday, Bloomberg reported that the Cerberus Capital- backed food and drug retailer Albertsons Cos had held...

  • Bad news about new cholesterol drugs

    There's a major advancement in fighting heart disease, but the new drug behind it is not cheap. CNBC's Meg Tirrell reports the latest on this cholesterol drug from Amgen.

  • Cummings: Plan to file drug pricing bill in 2 weeks

    CNBC's Eamon Javers reports on the outcome of President Trump's meeting with on Rep. Elijah Cummings (D-Maryland) over prescription drug pricing, as well as the president's meeting with business leaders on infrastructure.

  • Cummings: Trump liked our proposal on drug prices

    Rep. Elijah Cummings (D-Maryland) makes remarks after meeting with President Trump over prescription drug pricing, African American communities and voter fraud. With Rep. Peter Welch (D-Vermont).

  • Cramer weighs in on Mylan

    CNBC's Jim Cramer weighs in on Mylan and CEO Heather Bresch.